Deep brain stimulation (DBS)

Revision as of 08:46, 13 June 2021 by Geoffrey (talk | contribs) (Created page with "Treatment of major depressive disorder has been studied in subcallosal deep brain stimulation 159 A blinded controlled trial failed to produce significant difference between a...")
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)

Treatment of major depressive disorder has been studied in subcallosal deep brain stimulation 159 A blinded controlled trial failed to produce significant difference between active and sham stimulation at a 6-month endpoint. Authors argue that when looking at a longer timeline (18-24 months) in an open-label study there is greater observed benefit, which persists > 8 years later.159


References

Crowell, A. L. et al. Long-Term Outcomes of Subcallosal Cingulate Deep Brain Stimulation for Treatment-Resistant Depression. Am. J. Psychiatry 176, 949–956 (2019). https://pubmed.ncbi.nlm.nih.gov/31581800/

Retrieved from "https://ectopicbrain.bwh.harvard.edu/index.php?title=Deep_brain_stimulation_(DBS)&oldid=271"